State Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Signaling Network, School of Life Sciences, Xiamen University, Xiamen, Fujian, China.
Zhongshan Hospital of Xiamen University, Xiamen, Fujian, China.
Hepatology. 2017 Apr;65(4):1206-1221. doi: 10.1002/hep.28911. Epub 2016 Dec 19.
Great progress has been achieved in the study of Hippo signaling in regulating tumorigenesis; however, the downstream molecular events that mediate this process have not been completely defined. Moreover, regulation of Hippo signaling during tumorigenesis in hepatocellular carcinoma (HCC) remains largely unknown. In the present study, we systematically investigated the relationship between Yes-associated protein/TEA domain family member (YAP-TEAD) and hepatocyte nuclear factor 4-alpha (HNF4α) in the hepatocarcinogenesis of HCC cells. Our results indicated that HNF4α expression was negatively regulated by YAP1 in HCC cells by a ubiquitin proteasome pathway. By contrast, HNF4α was found to directly associate with TEAD4 to compete with YAP1 for binding to TEAD4, thus inhibiting the transcriptional activity of YAP-TEAD and expression of their target genes. Moreover, overexpression of HNF4α was found to significantly compromise YAP-TEAD-induced HCC cell proliferation and stem cell expansion. Finally, we documented the regulatory mechanism between YAP-TEAD and HNF4α in rat and mouse tumor models, which confirmed our in vitro results.
There is a double-negative feedback mechanism that controls TEAD-YAP and HNF4α expression in vitro and in vivo, thereby regulating cellular proliferation and differentiation. Given that YAP acts as a dominant oncogene in HCC and plays a crucial role in stem cell homeostasis and tissue regeneration, manipulating the interaction between YAP, TEADs, and HNF4α may provide a new approach for HCC treatment and regenerative medicine. (Hepatology 2017;65:1206-1221).
在 Hippo 信号调控肿瘤发生方面已经取得了很大的进展;然而,介导这一过程的下游分子事件尚未完全确定。此外,Hippo 信号在肝癌(HCC)中的肿瘤发生中的调控仍知之甚少。在本研究中,我们系统地研究了 Yes 相关蛋白/TEA 结构域家族成员(YAP-TEAD)和肝细胞核因子 4α(HNF4α)在 HCC 细胞肝癌发生中的关系。我们的结果表明,HNF4α 的表达在 HCC 细胞中通过泛素蛋白酶体途径受到 YAP1 的负调控。相比之下,发现 HNF4α 直接与 TEAD4 结合,与 YAP1 竞争与 TEAD4 的结合,从而抑制 YAP-TEAD 的转录活性和其靶基因的表达。此外,发现 HNF4α 的过表达显著削弱了 YAP-TEAD 诱导的 HCC 细胞增殖和干细胞扩增。最后,我们在大鼠和小鼠肿瘤模型中记录了 YAP-TEAD 和 HNF4α 之间的调节机制,证实了我们的体外结果。
体外和体内存在一种双重负反馈机制,控制 TEAD-YAP 和 HNF4α 的表达,从而调节细胞增殖和分化。鉴于 YAP 在 HCC 中作为显性癌基因发挥作用,并且在干细胞稳态和组织再生中发挥关键作用,操纵 YAP、TEADs 和 HNF4α 之间的相互作用可能为 HCC 治疗和再生医学提供一种新方法。(《肝脏病学》2017;65:1206-1221)。